The HH-60W helped rescue a pilot in Iran. Here’s why the Air Force might not buy more.

Key event: the Air Force's FY2027 budget requests $0 for additional HH-60W (Jolly Green II) procurements, despite an original program of record of 113 aircraft, a FY23 cap at 75, and budget documents showing the program later raised to at least 89 with a $100M congressional FY26 plus-up. The HH-60W was reportedly used for the first combat recovery in Iran, drawing public praise and increasing political attention; Senator Richard Blumenthal plans to push for more buys, likely triggering a Congressional fight that could affect Lockheed/Sikorsky production and revenues. The Air Force issued an RFI for advanced infrared countermeasures to upgrade the fleet, while alternative platforms (Army MV-75 and DARPA's SPRINT/X-76) could begin deliveries/flight tests in 2028.

Analysis

A recent high-profile operational demonstration has amplified the political spotlight on personnel-recovery rotorcraft, converting what was a programmatic procurement debate into a near-term legislative risk/reward trade. That shift magnifies the importance of aftermarket integration (countermeasures, sensors, missionization) relative to new airframe buys: vendors that can win retrofit contracts can extract multi-year, recurring revenue even if new-production rates are capped.

Production-rate friction favors incumbent airframe integrators and their local supplier bases — gearbox, rotor, avionics and mission-compute vendors with 12–24 month lead-times — because marginal increases in buy quantity move backlog and utilization steeply given currently lean shop capacity. Conversely, programs pitched as “future” replacements (high-speed or service-dominant alternatives) create a 3–7 year dilution risk for current-platform demand; that window is where DARPA/Army test programs and certification timelines matter most.

Political outcomes are the primary catalyst: a congressionally driven plus-up or NDAA insertion would generate concentrated revenue and a bump to orderly supply-chain hiring/capex within 6–12 months, while a sustained doctrinal pivot toward Indo-Pacific, with emphasis on long-range survivability, would structurally cap buys and push value into mission systems and multi-domain platforms. Key tactical readouts to watch are the RFI awardees for infrared countermeasures and any near-term appropriations riders — each can move vendor equity by 10–20% on expectation shifts.

Tail risks include a high-casualty event that forces emergency buys (accelerating short-cycle production) or integration failures that increase lifecycle costs and political pushback. The most balanced view: near-term upside is skewed to integrators and countermeasure suppliers; medium-term uncertainty centers on platform substitution risk driven by advanced prototypes and service threat priorities.

Key Decisions for Investors

• Long LMT (6–12 months): overweight the shares size 3–5% of portfolio to capture upside from retrofit work and any procurement plus-ups. Risk/reward: asymmetric — modest share move if no congressional support, +15–30% upside if incremental buys or high-margin integration awards materialize. Tactical stop: -8%; reduce size on +20% realized gain.
• Pair trade — Long LMT / Short BA (6 months): equal notional exposure to isolate procurement vs broader aerospace execution risk. Rationale: LMT should capture incremental share of any urgent buys and integration work, while BA is exposed to missed wins and higher program-opportunity costs. Risk management: cap short at 2% portfolio and hedge with call protection if volatility spikes.
• Play countermeasure vendors (12–24 months): buy positions in prime IRCM integrators (RTX/NOC or relevant suppliers) or use call spreads to limit premium outlay. Expect discrete awards — treat as event-driven with 20–30% target upside on contract announcements and quick reprice risk on competitor wins.
• Options idea: buy LMT 12–18 month calls (funded by selling nearer-dated calls) to capture upside from NDAA/appropriations while monetizing theta. Keep notional small (1–2% portfolio) due to policy execution risk; unwind on contract/RFI award or if legislative language explicitly caps buys for the multi-year budget window.